Declared Dividend • Jun 17
Dividend increased to Rp11.42 Dividend of Rp11.42 is 33% higher than last year. Ex-date: 23rd June 2026 Payment date: 15th July 2026 Dividend yield will be 0.4%, which is lower than the industry average of 0.6%. Payout Ratios Payout ratio: 31%. Cash payout ratio: 31%. Duyuru • Jun 16
PT Samator Indo Gas Tbk announces Annual dividend, payable on July 15, 2026 PT Samator Indo Gas Tbk announced Annual dividend of IDR 11.4200 per share payable on July 15, 2026, ex-date on June 23, 2026 and record date on June 24, 2026. Duyuru • May 06
PT Samator Indo Gas Tbk, Annual General Meeting, Jun 11, 2026 PT Samator Indo Gas Tbk, Annual General Meeting, Jun 11, 2026. Location: jakarta Indonesia Reported Earnings • May 05
First quarter 2026 earnings released: EPS: Rp11.00 (vs Rp2.53 in 1Q 2025) First quarter 2026 results: EPS: Rp11.00 (up from Rp2.53 in 1Q 2025). Revenue: Rp762.1b (up 7.9% from 1Q 2025). Net income: Rp35.2b (up 354% from 1Q 2025). Profit margin: 4.6% (up from 1.1% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in Indonesia. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Apr 16
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 105% to Rp3,300. The fair value is estimated to be Rp2,702, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Earnings per share has declined by 10%. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 172% in the next 2 years. Reported Earnings • Apr 02
Full year 2025 earnings released: EPS: Rp19.00 (vs Rp34.22 in FY 2024) Full year 2025 results: EPS: Rp19.00 (down from Rp34.22 in FY 2024). Revenue: Rp3.01t (up 3.5% from FY 2024). Net income: Rp58.4b (down 44% from FY 2024). Profit margin: 1.9% (down from 3.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Indonesia. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Mar 30
Now 28% overvalued after recent price rise Over the last 90 days, the stock has risen 124% to Rp3,400. The fair value is estimated to be Rp2,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 73% in the next 2 years. New Risk • Feb 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin). Buy Or Sell Opportunity • Feb 20
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 123% to Rp3,120. The fair value is estimated to be Rp2,508, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.2% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 73% in the next 2 years. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to Rp1,950, the stock trades at a trailing P/E ratio of 70.7x. Average trailing P/E is 17x in the Chemicals industry in Indonesia. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Nov 26
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to Rp1,580, the stock trades at a trailing P/E ratio of 57.3x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total loss to shareholders of 29% over the past three years. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to Rp1,430, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total loss to shareholders of 34% over the past three years. New Risk • Nov 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indonesian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 5.2% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (2.8% net profit margin). Reported Earnings • Nov 03
Third quarter 2025 earnings released: EPS: Rp14.44 (vs Rp4.94 in 3Q 2024) Third quarter 2025 results: EPS: Rp14.44 (up from Rp4.94 in 3Q 2024). Revenue: Rp793.7b (up 7.6% from 3Q 2024). Net income: Rp38.0b (up 151% from 3Q 2024). Profit margin: 4.8% (up from 2.1% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Board Change • Oct 24
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 4 highly experienced directors. No independent directors (8 non-independent directors). Independent Commissioner . Robiyanto was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 24
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to Rp1,440, the stock trades at a trailing P/E ratio of 71.6x. Average trailing P/E is 15x in the Chemicals industry in Indonesia. Total loss to shareholders of 26% over the past three years. Duyuru • May 08
PT Samator Indo Gas Tbk, Annual General Meeting, Jun 13, 2025 PT Samator Indo Gas Tbk, Annual General Meeting, Jun 13, 2025. Reported Earnings • Nov 01
Third quarter 2024 earnings released: EPS: Rp4.72 (vs Rp14.48 in 3Q 2023) Third quarter 2024 results: EPS: Rp4.72 (down from Rp14.48 in 3Q 2023). Revenue: Rp737.7b (up 1.1% from 3Q 2023). Net income: Rp15.1b (down 66% from 3Q 2023). Profit margin: 2.1% (down from 6.1% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Aug 01
Second quarter 2024 earnings released: EPS: Rp8.52 (vs Rp8.21 in 2Q 2023) Second quarter 2024 results: EPS: Rp8.52 (up from Rp8.21 in 2Q 2023). Revenue: Rp696.9b (up 5.7% from 2Q 2023). Net income: Rp27.3b (up 8.4% from 2Q 2023). Profit margin: 3.9% (up from 3.8% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Duyuru • May 19
PT Samator Indo Gas Tbk, Annual General Meeting, Jun 24, 2024 PT Samator Indo Gas Tbk, Annual General Meeting, Jun 24, 2024. Location: jakarta Indonesia Reported Earnings • May 12
Full year 2023 earnings released: EPS: Rp54.01 (vs Rp32.64 in FY 2022) Full year 2023 results: EPS: Rp54.01 (up from Rp32.64 in FY 2022). Revenue: Rp2.82t (up 8.0% from FY 2022). Net income: Rp165.4b (up 67% from FY 2022). Profit margin: 5.9% (up from 3.8% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Recent Insider Transactions • Dec 01
Bulk & Onsite Director and Director recently sold Rp37m worth of stock On the 24th of November, Budi Susanto sold around 25k shares on-market at roughly Rp1,465 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: Rp14.18 (vs Rp6.50 in 3Q 2022) Third quarter 2023 results: EPS: Rp14.18 (up from Rp6.50 in 3Q 2022). Revenue: Rp729.9b (up 15% from 3Q 2022). Net income: Rp44.4b (up 124% from 3Q 2022). Profit margin: 6.1% (up from 3.1% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings. Reported Earnings • Aug 05
Second quarter 2023 earnings released: EPS: Rp8.21 (vs Rp2.03 in 2Q 2022) Second quarter 2023 results: EPS: Rp8.21 (up from Rp2.03 in 2Q 2022). Revenue: Rp659.2b (up 13% from 2Q 2022). Net income: Rp25.2b (up 307% from 2Q 2022). Profit margin: 3.8% (up from 1.1% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Apr 07
Full year 2022 earnings released: EPS: Rp32.63 (vs Rp66.90 in FY 2021) Full year 2022 results: EPS: Rp32.63 (down from Rp66.90 in FY 2021). Revenue: Rp2.61t (down 4.6% from FY 2021). Net income: Rp99.3b (down 51% from FY 2021). Profit margin: 3.8% (down from 7.5% in FY 2021). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Dec 02
Third quarter 2022 earnings released: EPS: Rp6.50 (vs Rp25.51 in 3Q 2021) Third quarter 2022 results: EPS: Rp6.50 (down from Rp25.51 in 3Q 2021). Revenue: Rp636.1b (down 18% from 3Q 2021). Net income: Rp19.8b (down 75% from 3Q 2021). Profit margin: 3.1% (down from 10.0% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 57% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Commissioner Agoest Soebhektie was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment deteriorated over the past week After last week's 15% share price decline to Rp1,910, the stock trades at a trailing P/E ratio of 36.4x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 220% over the past three years. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment improved over the past week After last week's 17% share price gain to Rp2,520, the stock trades at a trailing P/E ratio of 48x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 309% over the past three years. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: Rp2.03 (vs Rp14.96 in 2Q 2021) Second quarter 2022 results: EPS: Rp2.03 (down from Rp14.96 in 2Q 2021). Revenue: Rp583.8b (down 11% from 2Q 2021). Net income: Rp6.18b (down 86% from 2Q 2021). Profit margin: 1.1% (down from 7.0% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to Rp1,950, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 271% over the past three years. Reported Earnings • May 23
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: Rp14.60 (down from Rp16.22 in 1Q 2021). Revenue: Rp682.6b (up 6.2% from 1Q 2021). Net income: Rp44.4b (down 10.0% from 1Q 2021). Profit margin: 6.5% (down from 7.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 6 non-independent directors. Independent Commissioner Agoest Soebhektie was the last independent director to join the board, commencing their role in 2013. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 18
Investor sentiment improved over the past week After last week's 24% share price gain to Rp2,450, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 22x in the Chemicals industry in Indonesia. Total returns to shareholders of 358% over the past three years. Reported Earnings • Apr 12
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: Rp66.90 (up from Rp31.59 in FY 2020). Revenue: Rp2.74t (up 25% from FY 2020). Net income: Rp204.2b (up 112% from FY 2020). Profit margin: 7.5% (up from 4.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 45%. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improved over the past week After last week's 16% share price gain to Rp1,645, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 22x in the Chemicals industry in Indonesia. Total returns to shareholders of 199% over the past three years. Valuation Update With 7 Day Price Move • Dec 17
Investor sentiment improved over the past week After last week's 17% share price gain to Rp1,725, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 38x in the Chemicals industry in Indonesia. Total returns to shareholders of 172% over the past three years. Reported Earnings • Nov 03
Third quarter 2021 earnings released: EPS Rp25.50 (vs Rp4.28 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: Rp778.8b (up 43% from 3Q 2020). Net income: Rp77.6b (up Rp64.8b from 3Q 2020). Profit margin: 10.0% (up from 2.3% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improved over the past week After last week's 18% share price gain to Rp1,600, the stock trades at a forward P/E ratio of 45x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 158% over the past three years. Reported Earnings • Aug 31
Second quarter 2021 earnings released: EPS Rp14.79 (vs Rp0.74 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: Rp653.1b (up 34% from 2Q 2020). Net income: Rp45.5b (up Rp47.8b from 2Q 2020). Profit margin: 7.0% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment deteriorated over the past week After last week's 16% share price decline to Rp1,460, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 156% over the past three years. Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improved over the past week After last week's 26% share price gain to Rp1,340, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 16x in the Chemicals industry in Asia. Total returns to shareholders of 118% over the past three years. Reported Earnings • May 09
First quarter 2021 earnings released: EPS Rp16.22 (vs Rp6.19 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: Rp642.7b (up 18% from 1Q 2020). Net income: Rp49.4b (up 160% from 1Q 2020). Profit margin: 7.7% (up from 3.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Apr 11
Full year 2020 earnings released: EPS Rp31.59 (vs Rp32.93 in FY 2019) The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: Rp2.19t (flat on FY 2019). Net income: Rp96.4b (down 4.5% from FY 2019). Profit margin: 4.4% (down from 4.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment deteriorated over the past week After last week's 15% share price decline to Rp1,040, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 18x in the Chemicals industry in Asia. Total returns to shareholders of 47% over the past three years. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improved over the past week After last week's 18% share price gain to Rp1,465, the stock is trading at a trailing P/E ratio of 78.3x, up from the previous P/E ratio of 66.3x. This compares to an average P/E of 17x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 98%. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment deteriorated over the past week After last week's 25% share price decline to Rp1,395, the stock is trading at a trailing P/E ratio of 74.6x, down from the previous P/E ratio of 99.2x. This compares to an average P/E of 15x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 75%. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment improved over the past week After last week's 22% share price gain to Rp1,155, the stock is trading at a trailing P/E ratio of 61.8x, up from the previous P/E ratio of 50.5x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 48%. Is New 90 Day High Low • Jan 04
New 90-day high: Rp990 The company is up 94% from its price of Rp510 on 07 October 2020. The Indonesian market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. Reported Earnings • Dec 04
Third quarter 2020 earnings released: EPS Rp4.28 The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: Rp546.5b (down 3.3% from 3Q 2019). Net income: Rp12.8b (down 56% from 3Q 2019). Profit margin: 2.3% (down from 5.2% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Nov 19
Market bids up stock over the past week After last week's 25% share price gain to Rp930, the stock is trading at a trailing P/E ratio of 38.7x, up from the previous P/E ratio of 31x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 51%. Valuation Update With 7 Day Price Move • Nov 05
Market bids up stock over the past week After last week's 16% share price gain to Rp750, the stock is trading at a trailing P/E ratio of 31.2x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 13x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 26%. Valuation Update With 7 Day Price Move • Nov 03
Market bids up stock over the past week After last week's 18% share price gain to Rp760, the stock is trading at a trailing P/E ratio of 31.6x, up from the previous P/E ratio of 26.9x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 27%. Is New 90 Day High Low • Nov 02
New 90-day high: Rp695 The company is up 28% from its price of Rp545 on 04 August 2020. The Indonesian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Valuation Update With 7 Day Price Move • Oct 15
Market bids up stock over the past week After last week's 18% share price gain to Rp590, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.8x. This compares to an average P/E of 16x in the Chemicals industry in Indonesia. Total returns to shareholders over the past three years are 3.3%. Is New 90 Day High Low • Oct 15
New 90-day high: Rp590 The company is up 4.0% from its price of Rp570 on 17 July 2020. The Indonesian market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 8.0% over the same period.